ProBioGen grants a license for human lymph node technology to TissUse for Multi-Organ-Chip applications
ProBioGen AG and TissUse GmbH have signed a license and cooperation agreement to integrate ProBioGen’s Human Artificial…
ProBioGen AG and TissUse GmbH have signed a license and cooperation agreement to integrate ProBioGen’s Human Artificial…
AFFiRiS AG will explore ProBioGen's proprietary Human Artificial Lymph Node Technology (HuALN) as analytical tool for it…
ProBioGen AG, a leading biotechnology company in cell engineering and production of biopharmaceuticals, today announced…
ProBioGen AG, ein führendes Biotechnologieunternehmen in den Bereichen Zellliniendesign und Herstellung von Biopharmaze…